Meta-analysis in the design and monitoring of clinical trials.
about
Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-AnalysisPrognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published DataClinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature reviewThe diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysisThe clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic reviewA meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancerThe clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature reviewAssociation between Retinoic acid receptor-β hypermethylation and NSCLC risk: a meta-analysis and literature reviewGlobal eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapySummarizing historical information on controls in clinical trialsPromoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.The effect of warm-up on surgical performance: a systematic review.The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.Bayesian design using adult data to augment pediatric trials.Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trialsMethods in health service research. An introduction to bayesian methods in health technology assessmentGene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood.HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis.The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data.Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism.MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular featuresClinical efficacy of spironolactone for resistant hypertension: a meta analysis from randomized controlled clinical trials.Clinicopathological significance and potential drug target of RUNX3 in breast cancer.Clinicopathological significance and potential drug target of T-cadherin in NSCLC.Association between transforming growth factor-beta 1 T869C polymorphism and ischemic stroke: a meta-analysis.The acute effects of grape polyphenols supplementation on endothelial function in adults: meta-analyses of controlled trials.Contrast sensitivity and spherical aberration in eyes implanted with AcrySof IQ and AcrySof Natural intraocular lens: the results of a meta-analysis.Relationship between interleukin-10 -1082A/G polymorphism and risk of ischemic stroke: a meta-analysis.Clinicopathological significance of CXCR4 in non-small cell lung cancer.Association between SERPING1 rs2511989 polymorphism and age-related macular degeneration: Meta-analysis.Effect of Grape Polyphenols on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials.Association of Thrombomodulin Gene Polymorphisms with Susceptibility to Atherosclerotic Diseases: A Meta-Analysis.The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis.Complications of lung resection and exercise capacity: a meta-analysisClinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysisLeptin receptor gene polymorphisms and risk of hypertension: a meta-analysisThe Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis.DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.Promoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptor-negative tumors and the prognosis of breast cancer: A meta-analysis
P2860
Q26748676-4B1F7506-A77A-403C-9CA7-EB1E50B96888Q26775998-C9CE249E-16E0-4AC2-8C89-B04E436F8F29Q26830809-2D42BF4B-D8BE-414F-A9CA-9E05A27D1D96Q26865165-E246DE40-DE44-4134-B00A-9136F883D5ECQ26865748-EB9343BB-42F1-4A65-833D-F31DF7CB2DBAQ26998677-D4CFB849-6CD0-4564-BC90-D3082BA2A601Q28068822-90D5D498-5771-4D8E-A2D4-82F699A172F8Q28080155-63AA60D7-99B6-4479-8505-8133618A03F5Q28296156-DEB30A9A-1DAE-4D74-9C09-425F999E0E10Q29397593-360DA4A8-E97D-4B45-96D5-C51879039135Q30240147-C5ED4FFE-8F4E-4EEC-B8B0-79B5D1D0CBF0Q30365992-53A0D550-51B2-4E10-A3CF-A51EC705B659Q30651861-CBA654AA-4B6E-49F1-82A3-3C8E08856AE2Q33492143-BAF06879-D2F6-4E55-9B47-206214E2D6AAQ33603685-C7A9FD08-9513-472A-8A71-19588172E38EQ33691735-264BA053-51D8-41DD-A530-2E0F66C8976EQ33716256-FE8612B1-F664-4CAA-993F-D285D4863346Q33761873-EE8D6220-4CE1-4CDB-B94D-6F53618F3151Q33777428-5D352718-DD72-4054-A873-F43E68994000Q34277400-696A56FE-2DF4-4072-9C70-EDD67B66B457Q34438114-A05CB006-B0BB-4674-8E27-A5E55860883FQ34650716-34408CE1-857D-47AF-9DE9-6A25B608D5FEQ34671912-98B439E1-8354-4E41-AF96-16B698319CF7Q34700919-3DF58CE0-3425-4906-9F07-AB9ABB30175AQ34783319-EBA3E6C8-2DDB-4313-89F1-93E11A04CC74Q34826026-9856AB71-0DE6-4B8F-91C7-C560CDD40D2FQ34874547-B8790564-E932-4D8A-9C08-8CE0E1AB427CQ35035698-CF1CF850-29AD-4143-B4A4-968AB3878918Q35147593-CEF90772-B6D4-4891-96FD-CDF9AB045FEBQ35171366-6445A522-79BB-490B-ACA6-66EFB381BE93Q35550015-DD7CCC0D-B485-4FCF-9937-0ED3CA2FA694Q35776953-DFF2F362-A272-4C40-8D10-4F8AC3C3E7EAQ35926786-B5117AC9-B676-4D50-9B3B-4D1F13064235Q35986338-1A88932B-886A-4288-8A13-E4BB4E176ADEQ36013231-B040278D-0C89-4D24-B526-91B408F2D35CQ36117964-99019BF0-2F98-4081-921C-F25253B704B2Q36183603-AE192347-CBFF-4A87-BE16-AE3AFCAAF5CDQ36185826-141F61A6-9FC9-4789-82A1-6DDBFC99611AQ36209868-F51057BA-3405-4CD4-92E4-F88736175A70Q36334551-79FBABD8-06FC-4F39-BC53-534BD678F137
P2860
Meta-analysis in the design and monitoring of clinical trials.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Meta-analysis in the design and monitoring of clinical trials.
@en
Meta-analysis in the design and monitoring of clinical trials.
@nl
type
label
Meta-analysis in the design and monitoring of clinical trials.
@en
Meta-analysis in the design and monitoring of clinical trials.
@nl
prefLabel
Meta-analysis in the design and monitoring of clinical trials.
@en
Meta-analysis in the design and monitoring of clinical trials.
@nl
P1476
Meta-analysis in the design and monitoring of clinical trials.
@en
P2093
DerSimonian R
P304
1237-48; discussion 1249-52
P356
10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N
P407
P577
1996-06-01T00:00:00Z